Outcome reporting bias in clinical trials: why monitoring matters

Affiliations

¹ Departments of Medicine, Health Research and Policy, and Statistics, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Palo Alto, CA 94305, USA jioannid@stanford.edu.
² Division of Medical Ethics, School of Medicine, NYU Langone Medical Center, New York, NY 10016, USA.
³ Clinical Research, BUC (Biosciences UAM+CSIC) Program, International Campus of Excellence, Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.

John Pa Ioannidis et al. BMJ. 2017.

. 2017 Feb 14:356:j408.

doi: 10.1136/bmj.j408.

¹ Departments of Medicine, Health Research and Policy, and Statistics, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Palo Alto, CA 94305, USA jioannid@stanford.edu.
² Division of Medical Ethics, School of Medicine, NYU Langone Medical Center, New York, NY 10016, USA.
³ Clinical Research, BUC (Biosciences UAM+CSIC) Program, International Campus of Excellence, Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, Madrid 28049, Spain.

No abstract available

MeSH terms